IOTA Design
Develops affordable 3D bioprinting platforms and multi-scale scaffolds for skin tissue regeneration, alongside automated biofluid microsampling technologies for clinical diagnostics.
- CEO / Founder
- Pradeep Kumar Verma
- Team Size
- 1-10
- Stage
- Early Stage
- Total Funding
- $60K
- Latest Round
- Grant
- Key Investors
- BIRAC; IIT Kanpur
Technology & Products
Key Products
Multi-scale Scaffold for Skin Tissue; Blood Microsampler; 3D Printing Services; Product Design Services
Technological Advantage
CLAIMED: Affordable high-precision bioprinting for tissue engineering. VERIFIED: BIRAC BIG grant recipient for technical innovation in biomedical devices. DEFENSIBLE: Proprietary processes for scaffold generation.
Differentiation
Value Proposition
Reduces the cost of entry for tissue engineering research by providing bioprinting systems at a fraction of the cost of industrial incumbents, while automating blood sampling to improve diagnostic accuracy and patient comfort.
How They Differentiate
Focuses on 'affordable' bioprinting and integrated microsampling, targeting the price-sensitive Indian research market where high-end systems like Cellink are cost-prohibitive.
Market & Competition
Target Customers
Biomedical researchers, pharmaceutical companies, and hospitals requiring affordable tissue engineering and diagnostic tools.
Industry Verticals
Medical; Healthcare; Pharmaceuticals
Competitors
Cellink; Allevi; Pandorum Technologies
Growth & Milestones
Growth Metrics
Recipient of BIRAC BIG grant (~$60K); Incubated at IIT Kanpur SIIC; Expanded from R&D to commercial 3D printing services.
Major Milestones
2019: Founded; 2020: Received BIRAC BIG Grant; 2021: Developed Blood Microsampler prototype; 2022: Launched 3D printing services.
Notable Customers
EV Elecson India; NIT Rourkela (National Institute of Technology Rourkela); Central University of Gujarat (CUG)